Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa

The antifibrinolytic function of factor XIII is exclusively expressed through  2-antiplasmin cross-linking

(2011) S. R. Fraser et al.   BLOOD

Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis

(2009) William P Sheffield et al.   BMC BIOTECHNOLOGY

FcRn binding properties of an abnormal truncated analbuminemic albumin variant

(2009) Jan Terje Andersen et al.   CLINICAL BIOCHEMISTRY

Factor XIII Deficiency

(2009) Mehran Karimi et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Molecular MRI of Early Thrombus Formation Using a Bimodal α2-Antiplasmin–Based Contrast Agent

(2009) Robbert-Jan J.H.M. Miserus et al.   JACC-Cardiovascular Imaging

Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin

(2008) Yue-Jin Huang et al.   BMC BIOTECHNOLOGY

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

(2008) Felix Kratz   JOURNAL OF CONTROLLED RELEASE

Evidence that α2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation

(2008) M. W. MOSESSON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS